Literature DB >> 8466947

Stimulation of mycolic acid biosynthesis by incorporation of cis-tetracos-5-enoic acid in a cell-wall preparation from Mycobacterium smegmatis.

P R Wheeler1, G S Besra, D E Minnikin, C Ratledge.   

Abstract

Mycolic acids are high molecular weight hydroxy fatty acids which are a covalently linked part of the cell wall structure of all mycobacteria and their biosynthetic pathways offer potential drug targets. Three good candidates, cis-tetracos-5-enoic acid and R or S trans-6-methyl-tetracos-4-enoic acids, for the key initial intermediates where mycolic acid biosynthesis might diverge from other metabolic pathways, were tested as possible substrates. A cell-wall preparation from Mycobacterium smegmatis, capable of mycolic acid synthesis, was developed to investigate the possible incorporation of these, and other 16 to 24 carbon acids into mycolic acids. The wall preparations were extracted with hexane and suspended in hexane/water (7:1, v/v), and in this low-water assay, only one of these acids, cis-tetracos-5-enoic acid, stimulated the incorporation of radioactive label from [1-14C]acetate into alpha- and alpha'-mycolic acids. The extraction method used did, however, abolish some enzyme activity and mycolic acid biosynthesis was not completely restored by cis-tetracos-5-enoate. The two methyl-branched acids did not enhance the amount of label in epoxymycolic acids. An initial key intermediate in the synthesis of alpha- and alpha'-mycolic acids has therefore been positively identified for the first time; intermediates in the initial stages of the biosynthesis of oxygenated mycolic acids such as epoxymycolates remain to be defined.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8466947     DOI: 10.1016/0005-2760(93)90160-b

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Development of cyclobutene- and cyclobutane-functionalized fatty acids with inhibitory activity against Mycobacterium tuberculosis.

Authors:  Wantanee Sittiwong; Denise K Zinniel; Robert J Fenton; Darrell D Marshall; Courtney B Story; Bohkyung Kim; Ji-Young Lee; Robert Powers; Raúl G Barletta; Patrick H Dussault
Journal:  ChemMedChem       Date:  2014-06-05       Impact factor: 3.466

2.  A mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids accumulates meromycolates.

Authors:  J Liu; H Nikaido
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis.

Authors:  R A Slayden; R E Lee; J W Armour; A M Cooper; I M Orme; P J Brennan; G S Besra
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

4.  Determination of the primary target for isoniazid in mycobacterial mycolic acid biosynthesis with Mycobacterium aurum A+.

Authors:  P R Wheeler; P M Anderson
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

5.  Identification of the apparent carrier in mycolic acid synthesis.

Authors:  G S Besra; T Sievert; R E Lee; R A Slayden; P J Brennan; K Takayama
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

6.  Biogenesis of the mycobacterial cell wall and the site of action of ethambutol.

Authors:  K Mikusová; R A Slayden; G S Besra; P J Brennan
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

7.  Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis.

Authors:  Y Yuan; R E Lee; G S Besra; J T Belisle; C E Barry
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

8.  Mycobacterium tuberculosis Rv3802c encodes a phospholipase/thioesterase and is inhibited by the antimycobacterial agent tetrahydrolipstatin.

Authors:  Sarah K Parker; Robert M Barkley; John G Rino; Michael L Vasil
Journal:  PLoS One       Date:  2009-01-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.